4.8 Article

Liver transplantation using Donation after Cardiac Death donors

期刊

JOURNAL OF HEPATOLOGY
卷 56, 期 2, 页码 474-485

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2011.07.004

关键词

-

资金

  1. Roche
  2. Astellas
  3. Northern Counties Kidney research fund
  4. Royal College of Surgeons of England and Edinburgh
  5. UK Transplant, Technology Strategy board, Aquix, Roche, Astellas
  6. Novartis

向作者/读者索取更多资源

The success of solid organ transplantation has brought about burgeoning waiting lists with insufficient donation rates and substantial waiting list mortality. All countries have strived to expand donor numbers beyond the standard Donation after Brain Death (DBD). This has lead to the utilization of Donation after Cardiac Death (DCD) donors, also frequently referred to as Non-Heart Beating Donors (NHBD). Organs from these donors inevitably sustain warm ischaemic damage which varies in its extent and affects early graft function as well as graft survival. As a consequence, 'non-vital' organs such as renal transplants have increased rapidly from DCD donors but more 'vital' organ transplants such as the liver have lagged behind. However, an increasing proportion of liver transplants are now derived from DCD donors. This article covers this expansion, current results, pitfalls, and steps taken to minimize complications and to improve outcome, and future developments that are likely to occur.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据